| UniProt/SwissProt ID: | FINC_HUMAN |
| Description: | fibronectin 1 [Source:HGNC Symbol;Acc:3778] |
| Location: | chr2 q35 |
| Node attribute: | PPI(source); ligand; gene |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| T1842 | KTETItGFQVD | fn3 | PhosphoSitePlus |
| T1762 | TPKEKtGPMKE | fn3 | PhosphoSitePlus |
| Y1206 | PDITGyRITTT | fn3 | PhosphoSitePlus |
| T136 | GRISCtIANRC | PhosphoSitePlus | |
| S2384 | ADREDsRE___ | PhosphoSitePlus; SysPTM | |
| S2354 | SYNQYsQRYHQ | PhosphoSitePlus | |
| Y641 | SHISKyILRWR | fn3 | PhosphoSitePlus |
| T1840 | RTKTEtITGFQ | fn3 | PhosphoSitePlus |
| S2353 | ADREDs | HPRD | |
| S2294 | ADREDs | HPRD | |
| Y372 | NGRTFySCTTE | fn2 | PhosphoSitePlus |
| T1743 | LSAQWtPPNVQ | fn3 | PhosphoSitePlus |
| S909 | SDTVPsPRDLQ | HPRD; SysPTM | |
| S1833 | TTITIsWRTKT | fn3 | PhosphoSitePlus |
| S968 | EVTGLsPGVTY | fn3 | PhosphoSitePlus |
| T960 | PISRNtFAEVT | fn3 | PhosphoSitePlus |
| Y1042 | GQPRQyNVGPS | fn3 | PhosphoSitePlus |
| S2285 | PGGEPsPEGTT | HPRD | |
| T1860 | TPIQRtIKPDV | fn3 | PhosphoSitePlus |
| Y937 | SAVTGyRVDVI | fn3 | PhosphoSitePlus |
| Y1884 | YKIYLyTLNDN | fn3 | PhosphoSitePlus |
| S2310 | PGGEPsPEGTT | HPRD | |
| S2259 | GTTGQsYNQYS | HPRD | |
| S2251 | PGGEPsPEGTT | HPRD | |
| Y2353 | QSYNQySQRYH | PhosphoSitePlus | |
| T972 | LSPGVtYYFKV | fn3 | PhosphoSitePlus |
| Y106 | YTGNTyRVGDT | fn1 | PhosphoSitePlus |
| S2432 | PGGEPsPEGTT | HPRD | |
| S2328 | ADREDs | HPRD | |
| S2131 | PGGEPsPEGTT | HPRD | |
| S2440 | GTTGQsYNQYS | HPRD | |
| Y588 | VRYQCyCYGRG | fn1 | PhosphoSitePlus |
| S904 | TGTPRsDTVPS | PhosphoSitePlus; HPRD | |
| S2139 | GTTGQsYNQYS | HPRD | |
| S2293 | GTTGQsYNQYS | HPRD | |
| S2174 | ADREDs | HPRD | |
| Y1879 | QPGTDyKIYLY | fn3 | PhosphoSitePlus |
| T1271 | AVPPPtDLRFT | fn3 | PhosphoSitePlus |
| T1855 | PANGQtPIQRT | fn3 | PhosphoSitePlus |
| Y2258 | DNGVNyKIGEK | fn1 | PhosphoSitePlus |
| Y101 | TCFDKyTGNTY | fn1 | PhosphoSitePlus |
| S2318 | GTTGQsYNQYS | HPRD | |
| Y2350 | TTGQSyNQYSQ | PhosphoSitePlus | |
| S2475 | ADREDs | HPRD | |
| T1786 | GLMVAtKYEVS | fn3 | PhosphoSitePlus |
| T2065 | R.RTTPPTTATPIR.H | SysPTM 2.0 | |
| T2067 | R.RTTPPTTATPIR.H | SysPTM 2.0 | |
| Dephosphorylation site |
| FINC_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000352696 | D2380N | HPI | Colorectal Cancer | 16959974 |
| ENSP00000399538 | C386F | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
| ENSP00000338200 | R1120P | Sjoblom2006, COSMIC | Breast Cancer | 16959974 |
| ENSP00000338200 | D2349N | Sjoblom2006, COSMIC | Intestines Cancer | 16959974 |
| ENSP00000338200 | T2132S | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000338200 | P363S | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000338200 | N104S | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000338200 | A1902V | COSMIC | Central Nervous System Neoplasms | |
| ENSP00000338200 | P910L | COSMIC | Skin Cancer | 21984974 |
| ENSP00000338200 | Q2169* | COSMIC | Intestines Cancer | 16959974 |
| ENSP00000338200 | K2019M | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000338200 | P300S | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000338200 | D940N | Sjoblom2006, COSMIC | Breast Cancer | 16959974 |
| ENSP00000338200 | Q2169X | BIOMART | Colorectal Cancer | 21930507, 21930502 |
| ENSP00000338200 | G264S | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000338200 | H2211R | COSMIC | Pancreatic Cancer | |
| ENSP00000352696 | D940N | Sjoblom2006, HPI | Breast Cancer | 16959974 |
| ENSP00000338200 | A1899T | COSMIC | Central Nervous System Neoplasms | |
| ENSP00000352696 | R1120P | Sjoblom2006, HPI | Breast Cancer | 16959974 |
| Differential expressed protein |
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|---|---|---|---|---|---|
| ENSP00000352696 | hepatitis C virus | Normal vs. Cancer | tissue | Up | 3.4 | 18715028 |
| ENSP00000352696 | hepatitis C virus | Normal vs. Cancer | tissue | Up | 4.9 | 18715028 |
| ENSP00000352696 | hepatitis B virus | Normal vs. Cancer | tissue | Down | 0.16 | 14726492 |
| ENSP00000352696 | hepatitis B virus | Normal vs. Cancer | tissue | Down | 0.32 | 14726492 |
| ENSP00000352696 | Lung Cancer | Normal vs. Cancer | tissue | Up | 2 | 17705522 |
| ENSP00000352696 | Pancreatic Cancer | Normal vs. Cancer | tissue | Down | 0.05 | 16215274 |
| ENSP00000352696 | Uterine Cancer | Normal vs. Cancer | tissue | Up | 17902640 | |
| ENSP00000352696 | Breast Cancer | Metastasis | tissue | Down | 0.4 | 19053527 |
| ENSP00000352696 | Oral Cancer | Normal vs. Cancer | tissue | Up | 9.9 | 19297561 |
| ENSP00000352696 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 18571811 | |
| ENSP00000352696 | Hepatocellular Carcinoma | Metastasis | cell line | Up | 2.2 | 19016532 |
| ENSP00000352696 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.02 | 20198662 |
| ENSP00000352696 | Breast Cancer | Metastasis | cell line | Down | 0.3 | 20198662 |
| ENSP00000352696 | Breast Cancer | Normal vs. Cancer | tissue | Up | 0.99 | 20739354 |
| ENSP00000352696 | Breast Cancer | Normal vs. Cancer | tissue | Up | 0.99 | 20739354 |
| ENSP00000352696 | Renal Cancer | Normal vs. Cancer | tissue | Up | 19164279 | |
| ENSP00000352696 | Ovarian Cancer | Metastasis | cell line | Down | 0.11 | 17892554 |
| ENSP00000352696 | Ovarian Cancer | Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) | tissue | Up | 3.3 | 19422301 |
| ENSP00000352696 | Pancreatic Cancer | Normal vs. Cancer | tissue | Up | 2.4 | 16230073 |
| Hyperphosphorylation site |
| FINC_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| FINC_HUMAN | ITB8_HUMAN | ligand -> receptor | HPMR |
| FINC_HUMAN | SDC1_HUMAN | other | KEGG |
| FINC_HUMAN | CD44_HUMAN | other | KEGG |
| ATF2_HUMAN | FINC_HUMAN | TF -> target gene | TRANSFAC |
| CREB1_HUMAN | FINC_HUMAN | TF -> target gene | TRANSFAC |
| JUN_HUMAN | FINC_HUMAN | TF -> target gene | TRANSFAC |
| NFIC_HUMAN | FINC_HUMAN | TF -> target gene | TRANSFAC |
| Function Annotation |
| KEGG Pathway |
| KEGG ID | Pathway |
|---|---|
| hsa05222 | Small cell lung cancer |
| hsa05100 | Bacterial invasion of epithelial cells |
| hsa04510 | Focal adhesion |
| hsa04810 | Regulation of actin cytoskeleton |
| hsa05200 | Pathways in cancer |
| hsa04512 | ECM-receptor interaction |
| hsa05146 | Amoebiasis |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0005793 | endoplasmic reticulum-Golgi intermediate compartme | IDA | cellular_component |
| GO:0016504 | peptidase activator activity | IEA | molecular_function |
| GO:0005578 | proteinaceous extracellular matrix | NAS | cellular_component |
| GO:0010952 | positive regulation of peptidase activity | IEA | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0050900 | leukocyte migration | TAS | biological_process |
| GO:0006953 | acute-phase response | IEA | biological_process |
| GO:0007596 | blood coagulation | TAS | biological_process |
| GO:0031093 | platelet alpha granule lumen | TAS | cellular_component |
| GO:0005518 | collagen binding | NAS | molecular_function |
| GO:0016477 | cell migration | NAS | biological_process |
| GO:0005604 | basement membrane | IEA | cellular_component |
| GO:0008201 | heparin binding | NAS | molecular_function |
| GO:0002576 | platelet degranulation | TAS | biological_process |
| GO:0034446 | substrate adhesion-dependent cell spreading | IDA | biological_process |
| GO:0005576 | extracellular region | NAS | cellular_component |
| GO:0007044 | cell-substrate junction assembly | IEA | biological_process |
| GO:0005577 | fibrinogen complex | IDA | cellular_component |
| GO:0031012 | extracellular matrix | IDA | cellular_component |
| GO:0016324 | apical plasma membrane | IEA | cellular_component |
| GO:0007161 | calcium-independent cell-matrix adhesion | IEA | biological_process |
| GO:0018149 | peptide cross-linking | IDA | biological_process |
| GO:0007160 | cell-matrix adhesion | IEA | biological_process |
| GO:0007155 | cell adhesion | NAS | biological_process |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0005201 | extracellular matrix structural constituent | NAS | molecular_function |
| GO:0031012 | extracellular matrix | IEA | cellular_component |
| GO:0008360 | regulation of cell shape | IEA | biological_process |
| GO:0005615 | extracellular space | IDA | cellular_component |
| GO:0007155 | cell adhesion | IEA | biological_process |
| GO:0030168 | platelet activation | TAS | biological_process |
| GO:0042060 | wound healing | IEA | biological_process |
| GO:0009611 | response to wounding | NAS | biological_process |
| GO:0001525 | angiogenesis | IEA | biological_process |